Melanie Campbell is a Professor of Physics and Astronomy and in the School of Optometry at the University of Waterloo.
Melanie Campbell earned a BSc in Chemical Physics, Victoria University, University of Toronto, an MSc in Physics, University of Waterloo and, from the Australian National University, a PhD in Applied Mathematics and Physiology. Following a CSIRO Fellowship at the Institute of Mathematics and Statistics in Canberra, Campbell returned to Canada with an NSERC University Research Fellowship.
Melanie Campbell undertakes experimental and theoretical research in the optical quality of the eye and imaging of its structures. She studies eye development, eye disease and linear and nonlinear optics of the eye. Campbell is well known for her work on the gradient index optics of the crystalline lens, its changes with ageing and effects of visual experience on its refractive index distribution. She has developed and patented improved scanning laser and polarization methods for imaging the eye and biological tissues. She has collaborated in the first real-time images of cones at the rear of the eye, using adaptive optics. Recently she has discovered putative optical signals to eye growth which appear to follow a circadian rhythm. She uses ultrafast lasers to study highly localized light activated therapies for eye disease. Campbell is a Fellow of the Optical Society of America, a Fellow of the Institute of Physics (UK), holds an honorary Professional Physicist designation and is a former President of the Canadian Association of Physicists. Campbell was also a co-founder of Biomedical Photometrics Inc, now Huron Technologies. Campbell shared the 2004 Rank Prize in optoelectronics for her work cited as "an initial idea (that) has been carried through to practical applications that have, or will, demonstrably benefit mankind."